Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls.

Verani JR, Baqui AH, Broome CV, Cherian T, Cohen C, Farrar JL, Feikin DR, Groome MJ, Hajjeh RA, Johnson HL, Madhi SA, Mulholland K, O'Brien KL, Parashar UD, Patel MM, Rodrigues LC, Santosham M, Scott JA, Smith PG, Sommerfelt H, Tate JE, Victor JC, Whitney CG, Zaidi AK, Zell ER.

Vaccine. 2017 Jun 5;35(25):3295-3302. doi: 10.1016/j.vaccine.2017.04.037. Epub 2017 Apr 22. Review.

2.

Case-control vaccine effectiveness studies: Data collection, analysis and reporting results.

Verani JR, Baqui AH, Broome CV, Cherian T, Cohen C, Farrar JL, Feikin DR, Groome MJ, Hajjeh RA, Johnson HL, Madhi SA, Mulholland K, O'Brien KL, Parashar UD, Patel MM, Rodrigues LC, Santosham M, Scott JA, Smith PG, Sommerfelt H, Tate JE, Victor JC, Whitney CG, Zaidi AK, Zell ER.

Vaccine. 2017 Jun 5;35(25):3303-3308. doi: 10.1016/j.vaccine.2017.04.035. Epub 2017 Apr 23. Review.

3.

Bacterial meningitis surveillance in the Eastern Mediterranean region, 2005-2010: successes and challenges of a regional network.

Teleb N, Pilishvili T, Van Beneden C, Ghoneim A, Amjad K, Mostafa A, Estighamati AR, Smeo MN, Barkia A, Elkhatib M, Mujaly A, Ashmony H, Jassim KA, Hajjeh RA.

J Pediatr. 2013 Jul;163(1 Suppl):S25-31. doi: 10.1016/j.jpeds.2013.03.027.

4.

Case control study to identify risk factors for acute hepatitis C virus infection in Egypt.

Kandeel AM, Talaat M, Afifi SA, El-Sayed NM, Abdel Fadeel MA, Hajjeh RA, Mahoney FJ.

BMC Infect Dis. 2012 Nov 12;12:294. doi: 10.1186/1471-2334-12-294.

5.

International Conference on Emerging Infectious Diseases, 2010.

Marano N, Smith TL, Hajjeh RA, McDonald M, Bridges CB, Martin SA, Chorba T.

Emerg Infect Dis. 2010 Nov;16(11):e1. doi: 10.3201/eid1611.101370.

6.

Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience.

Hajjeh RA, Privor-Dumm L, Edmond K, O'Loughlin R, Shetty S, Griffiths UK, Bear AP, Cohen AL, Chandran A, Schuchat A, Mulholland EK, Santosham M.

Vaccine. 2010 Oct 8;28(43):7123-9. doi: 10.1016/j.vaccine.2010.07.028. Epub 2010 Jul 24.

PMID:
20659515
7.

Accelerating policy decisions to adopt haemophilus influenzae type B vaccine: a global, multivariable analysis.

Shearer JC, Stack ML, Richmond MR, Bear AP, Hajjeh RA, Bishai DM.

PLoS Med. 2010 Mar 16;7(3):e1000249. doi: 10.1371/journal.pmed.1000249.

8.

Establishment of public health security in Saudi Arabia for the 2009 Hajj in response to pandemic influenza A H1N1.

Memish ZA, McNabb SJ, Mahoney F, Alrabiah F, Marano N, Ahmed QA, Mahjour J, Hajjeh RA, Formenty P, Harmanci FH, El Bushra H, Uyeki TM, Nunn M, Isla N, Barbeschi M; Jeddah Hajj Consultancy Group.

Lancet. 2009 Nov 21;374(9703):1786-91. doi: 10.1016/S0140-6736(09)61927-9. Epub 2009 Nov 14. Review. Erratum in: Lancet. 2010 Jan 16;375(9710):200.

PMID:
19914707
9.

Cryptococcosis in Gauteng: implications for monitoring of HIV treatment programmes.

McCarthy KM, Cohen C, Schneider H, Gould SM, Brandt ME, Hajjeh RA; Gauteng Cryptococcal Surveillance Initiative Group.

S Afr Med J. 2008 Jun;98(6):452, 454. No abstract available.

PMID:
18683376
10.

Brucellosis as a cause of acute febrile illness in Egypt.

Jennings GJ, Hajjeh RA, Girgis FY, Fadeel MA, Maksoud MA, Wasfy MO, El-Sayed N, Srikantiah P, Luby SP, Earhart K, Mahoney FJ.

Trans R Soc Trop Med Hyg. 2007 Jul;101(7):707-13. Epub 2007 Apr 17.

PMID:
17442354
11.

Population-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence.

McCarthy KM, Morgan J, Wannemuehler KA, Mirza SA, Gould SM, Mhlongo N, Moeng P, Maloba BR, Crewe-Brown HH, Brandt ME, Hajjeh RA.

AIDS. 2006 Nov 14;20(17):2199-206.

PMID:
17086060
12.

Cryptococcus gattii infection: characteristics and epidemiology of cases identified in a South African province with high HIV seroprevalence, 2002-2004.

Morgan J, McCarthy KM, Gould S, Fan K, Arthington-Skaggs B, Iqbal N, Stamey K, Hajjeh RA, Brandt ME; Gauteng Cryptococcal Surveillance Initiative Group.

Clin Infect Dis. 2006 Oct 15;43(8):1077-80. Epub 2006 Sep 5.

PMID:
16983624
13.

Rapid enzyme-linked immunosorbent assay for the diagnosis of human brucellosis in surveillance and clinical settings in Egypt.

Fadeel MA, Wasfy MO, Pimentel G, Klena JD, Mahoney FJ, Hajjeh RA.

Saudi Med J. 2006 Jul;27(7):975-81.

PMID:
16830014
14.

Differentiation of tuberculous meningitis from acute bacterial meningitis using simple clinical and laboratory parameters.

Youssef FG, Afifi SA, Azab AM, Wasfy MM, Abdel-Aziz KM, Parker TM, Oun SA, Jobanputra NN, Hajjeh RA.

Diagn Microbiol Infect Dis. 2006 Aug;55(4):275-8. Epub 2006 Apr 19.

PMID:
16626906
15.

Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome.

Park BJ, Arthington-Skaggs BA, Hajjeh RA, Iqbal N, Ciblak MA, Lee-Yang W, Hairston MD, Phelan M, Plikaytis BD, Sofair AN, Harrison LH, Fridkin SK, Warnock DW.

Antimicrob Agents Chemother. 2006 Apr;50(4):1287-92.

16.

Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance.

Morgan J, Meltzer MI, Plikaytis BD, Sofair AN, Huie-White S, Wilcox S, Harrison LH, Seaberg EC, Hajjeh RA, Teutsch SM.

Infect Control Hosp Epidemiol. 2005 Jun;26(6):540-7. Erratum in: Infect Control Hosp Epidemiol. 2005 Aug;26(8):675.

PMID:
16018429
17.

Candidemia in pediatric outpatients receiving home total parenteral nutrition.

Cano MV, Perz JF, Craig AS, Liu M, Lyon GM, Brandt ME, Lott TJ, Lasker BA, Barrett FF, McNeil MM, Schaffner W, Hajjeh RA.

Med Mycol. 2005 May;43(3):219-25.

PMID:
16010848
18.

Determining risk factors for candidemia among newborn infants from population-based surveillance: Baltimore, Maryland, 1998-2000.

Shetty SS, Harrison LH, Hajjeh RA, Taylor T, Mirza SA, Schmidt AB, Sanza LT, Shutt KA, Fridkin SK.

Pediatr Infect Dis J. 2005 Jul;24(7):601-4.

PMID:
15999000
19.

An epidemic of coccidioidomycosis in Arizona associated with climatic changes, 1998-2001.

Park BJ, Sigel K, Vaz V, Komatsu K, McRill C, Phelan M, Colman T, Comrie AC, Warnock DW, Galgiani JN, Hajjeh RA.

J Infect Dis. 2005 Jun 1;191(11):1981-7. Epub 2005 Apr 20.

PMID:
15871133
20.

A large histoplasmosis outbreak among high school students in Indiana, 2001.

Chamany S, Mirza SA, Fleming JW, Howell JF, Lenhart SW, Mortimer VD, Phelan MA, Lindsley MD, Iqbal NJ, Wheat LJ, Brandt ME, Warnock DW, Hajjeh RA.

Pediatr Infect Dis J. 2004 Oct;23(10):909-14.

PMID:
15602189
21.

Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital.

Clark TA, Slavinski SA, Morgan J, Lott T, Arthington-Skaggs BA, Brandt ME, Webb RM, Currier M, Flowers RH, Fridkin SK, Hajjeh RA.

J Clin Microbiol. 2004 Oct;42(10):4468-72.

22.

Candida parapsilosis characterization in an outbreak setting.

Kuhn DM, Mikherjee PK, Clark TA, Pujol C, Chandra J, Hajjeh RA, Warnock DW, Soil DR, Ghannoum MA.

Emerg Infect Dis. 2004 Jun;10(6):1074-81.

23.

Coccidioidomycosis among workers at an archeological site, northeastern Utah.

Petersen LR, Marshall SL, Barton-Dickson C, Hajjeh RA, Lindsley MD, Warnock DW, Panackal AA, Shaffer JB, Haddad MB, Fisher FS, Dennis DT, Morgan J.

Emerg Infect Dis. 2004 Apr;10(4):637-42.

24.

Histoplasmosis associated with exploring a bat-inhabited cave in Costa Rica, 1998-1999.

Lyon GM, Bravo AV, Espino A, Lindsley MD, Gutierrez RE, Rodriguez I, Corella A, Carrillo F, McNeil MM, Warnock DW, Hajjeh RA.

Am J Trop Med Hyg. 2004 Apr;70(4):438-42.

PMID:
15100461
25.

Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program.

Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, Mirza SA, Phelan M, Morgan J, Lee-Yang W, Ciblak MA, Benjamin LE, Sanza LT, Huie S, Yeo SF, Brandt ME, Warnock DW.

J Clin Microbiol. 2004 Apr;42(4):1519-27.

26.

A large outbreak of histoplasmosis among American travelers associated with a hotel in Acapulco, Mexico, spring 2001.

Morgan J, Cano MV, Feikin DR, Phelan M, Monroy OV, Morales PK, Carpenter J, Weltman A, Spitzer PG, Liu HH, Mirza SA, Bronstein DE, Morgan DJ, Kirkman LA, Brandt ME, Iqbal N, Lindsley MD, Warnock DW, Hajjeh RA; Acapulco Histoplasmosis Working Group.

Am J Trop Med Hyg. 2003 Dec;69(6):663-9.

PMID:
14740886
27.

Blastomycosis in Missouri: epidemiology and risk factors for endemic disease.

Cano MV, Ponce-de-Leon GF, Tippen S, Lindsley MD, Warwick M, Hajjeh RA.

Epidemiol Infect. 2003 Oct;131(2):907-14.

28.

Outbreak of dengue fever in Palau, Western Pacific: risk factors for infection.

Ashford DA, Savage HM, Hajjeh RA, McReady J, Bartholomew DM, Spiegel RA, Vorndam V, Clark GG, Gubler DG.

Am J Trop Med Hyg. 2003 Aug;69(2):135-40.

PMID:
13677368
29.

Recent trends in the epidemiology of invasive mycoses.

Clark TA, Hajjeh RA.

Curr Opin Infect Dis. 2002 Dec;15(6):569-74. Review.

PMID:
12821832
30.

Outbreak of invasive aspergillosis among renal transplant recipients.

Panackal AA, Dahlman A, Keil KT, Peterson CL, Mascola L, Mirza S, Phelan M, Lasker BA, Brandt ME, Carpenter J, Bell M, Warnock DW, Hajjeh RA, Morgan J.

Transplantation. 2003 Apr 15;75(7):1050-3.

PMID:
12698098
31.

Human immunodeficiency virus type 1 subtype and other factors associated with extrapulmonary Cryptococcosis among patients in Thailand with AIDS.

Amornkul PN, Hu DJ, Tansuphasawadikul S, Lee S, Eampokalap B, Likanonsakul S, Nelson R, Young NL, Hajjeh RA, Limpakarnjanarat K, Mastro TD.

AIDS Res Hum Retroviruses. 2003 Feb;19(2):85-90.

PMID:
12639243
32.

The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000.

Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, Gardner T, Sattah M, de Leon GP, Baughman W, Hajjeh RA.

Clin Infect Dis. 2003 Mar 15;36(6):789-94. Epub 2003 Feb 27.

PMID:
12627365
33.

Stability of allelic frequencies and distributions of Candida albicans microsatellite loci from U.S. population-based surveillance isolates.

Lott TJ, Fundyga RE, Brandt ME, Harrison LH, Sofair AN, Hajjeh RA, Warnock DW.

J Clin Microbiol. 2003 Mar;41(3):1316-21.

34.

Population-based surveillance and a case-control study of risk factors for endemic lymphocutaneous sporotrichosis in Peru.

Lyon GM, Zurita S, Casquero J, Holgado W, Guevara J, Brandt ME, Douglas S, Shutt K, Warnock DW, Hajjeh RA; Sporotrichosis in Peru Investigation Team.

Clin Infect Dis. 2003 Jan 1;36(1):34-9. Epub 2002 Dec 12.

PMID:
12491199
35.

Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001.

Dewan PK, Fry AM, Laserson K, Tierney BC, Quinn CP, Hayslett JA, Broyles LN, Shane A, Winthrop KL, Walks I, Siegel L, Hales T, Semenova VA, Romero-Steiner S, Elie C, Khabbaz R, Khan AS, Hajjeh RA, Schuchat A; Washington, D.C., Anthrax Response Team.

Emerg Infect Dis. 2002 Oct;8(10):1066-72.

36.

Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response.

Hsu VP, Lukacs SL, Handzel T, Hayslett J, Harper S, Hales T, Semenova VA, Romero-Steiner S, Elie C, Quinn CP, Khabbaz R, Khan AS, Martin G, Eisold J, Schuchat A, Hajjeh RA.

Emerg Infect Dis. 2002 Oct;8(10):1039-43.

37.

Fungal infections among returning travelers.

Panackal AA, Hajjeh RA, Cetron MS, Warnock DW.

Clin Infect Dis. 2002 Nov 1;35(9):1088-95. Epub 2002 Oct 11.

PMID:
12384843
38.

Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.

Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP; National Nosocomial Infections Surveillance System Hospitals.

Clin Infect Dis. 2002 Sep 1;35(5):627-30. Epub 2002 Aug 2.

PMID:
12173140
39.

Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates.

Arthington-Skaggs BA, Lee-Yang W, Ciblak MA, Frade JP, Brandt ME, Hajjeh RA, Harrison LH, Sofair AN, Warnock DW; Candidemia Active Surveillance Group.

Antimicrob Agents Chemother. 2002 Aug;46(8):2477-81.

40.

Automatic electronic laboratory-based reporting of notifiable infectious diseases at a large health system.

Panackal AA, M'ikanatha NM, Tsui FC, McMahon J, Wagner MM, Dixon BW, Zubieta J, Phelan M, Mirza S, Morgan J, Jernigan D, Pasculle AW, Rankin JT Jr, Hajjeh RA, Harrison LH.

Emerg Infect Dis. 2002 Jul;8(7):685-91.

41.

Surveillance for unexplained deaths and critical illnesses due to possibly infectious causes, United States, 1995-1998.

Hajjeh RA, Relman D, Cieslak PR, Sofair AN, Passaro D, Flood J, Johnson J, Hacker JK, Shieh WJ, Hendry RM, Nikkari S, Ladd-Wilson S, Hadler J, Rainbow J, Tappero JW, Woods CW, Conn L, Reagan S, Zaki S, Perkins BA.

Emerg Infect Dis. 2002 Feb;8(2):145-53.

42.

Epidemiology and Prevention of Invasive Aspergillosis.

Warnock DW, Hajjeh RA, Lasker BA.

Curr Infect Dis Rep. 2001 Dec;3(6):507-516.

PMID:
11722807
43.

Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998.

Brandt ME, Pfaller MA, Hajjeh RA, Hamill RJ, Pappas PG, Reingold AL, Rimland D, Warnock DW; Cryptococcal Disease Active Surveillance Group.

Antimicrob Agents Chemother. 2001 Nov;45(11):3065-9.

44.

Counterpoint: invasive aspergillosis and the environment--rethinking our approach to prevention.

Hajjeh RA, Warnock DW.

Clin Infect Dis. 2001 Nov 1;33(9):1549-52. Epub 2001 Sep 24. Review.

PMID:
11568854
45.

The epidemiology of histoplasmosis: a review.

Cano MV, Hajjeh RA.

Semin Respir Infect. 2001 Jun;16(2):109-18. Review.

PMID:
11521243
46.

Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.

McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD, Warnock DW.

Clin Infect Dis. 2001 Sep 1;33(5):641-7. Epub 2001 Jul 30. Review.

PMID:
11486286
47.

Adenovirus type 3 viremia in an adult with toxic shock-like syndrome.

Price NO, Hacker JK, Silvers JH, Crawford-Miksza L, Hendry RM, Flood J, Hajjeh RA, Reingold AL, Passaro DJ.

Clin Infect Dis. 2001 Jul 15;33(2):260-2. Epub 2001 Jun 20.

PMID:
11418888
48.

Gastrointestinal basidiobolomycosis in Arizona: clinical and epidemiological characteristics and review of the literature.

Lyon GM, Smilack JD, Komatsu KK, Pasha TM, Leighton JA, Guarner J, Colby TV, Lindsley MD, Phelan M, Warnock DW, Hajjeh RA.

Clin Infect Dis. 2001 May 15;32(10):1448-55. Epub 2001 Apr 20. Review.

PMID:
11317246
49.

Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons.

Hajjeh RA, Pappas PG, Henderson H, Lancaster D, Bamberger DM, Skahan KJ, Phelan MA, Cloud G, Holloway M, Kauffman CA, Wheat LJ; National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Clin Infect Dis. 2001 Apr 15;32(8):1215-20. Epub 2001 Mar 26.

PMID:
11283812
50.

Estimating the cost of nosocomial candidemia in the united states.

Miller LG, Hajjeh RA, Edwards JE Jr.

Clin Infect Dis. 2001 Apr 1;32(7):1110. No abstract available.

PMID:
11264044

Supplemental Content

Loading ...
Support Center